These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11366467)

  • 1. HE2000 begins clinical trials: interview with James Frincke, Ph.D. Interview by John S. James.
    Frincke J
    AIDS Treat News; 1999 Jun; (No 320):4-7. PubMed ID: 11366467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA explores new antiretroviral trial designs: interview with David Feigal, M.D. Interview by John S. James.
    Feigal D
    AIDS Treat News; 1997 Jun; (No 273):1-5. PubMed ID: 11364399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Starving the virus.
    Res Initiat Treat Action; 1999 Apr; 5(2):32-3. PubMed ID: 11366283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHEA clinical experience: interview with Jon Kaiser, M.D. Interview by John S. James.
    Kaiser J
    AIDS Treat News; 1996 Jan; (no 239):8. PubMed ID: 11363088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekend treatment interruptions for certain well-controlled patients: interview with Cal Cohen, M.D. Interview by John S. James.
    Cohen C
    AIDS Treat News; 2004; (407-408):2-4. PubMed ID: 15717379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New kind of antiretroviral, KP-1461; clinical trial recruiting. Interview with Stephen Becker, M.D.
    Becker S
    AIDS Treat News; 2007; (423):3-7. PubMed ID: 18411488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
    Reading C; Dowding C; Schramm B; Garsd A; Onizuka-Handa N; Stickney D; Frincke J
    Clin Microbiol Infect; 2006 Nov; 12(11):1082-8. PubMed ID: 17002607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviruses Conference clinical news; interview with Cal Cohen, M.D. Interview by John S. James.
    Cohen C
    AIDS Treat News; 2003 Mar; (389):2-6. PubMed ID: 12712936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS practice issues today: interview with Paul Bellman, M.D. Interview by John S. James.
    Bellman P
    AIDS Treat News; 2000 Apr; (No 340):1-6. PubMed ID: 11367198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New fixed dose once-a-day combinations. Interview by John S. James.
    Cohen C
    IAPAC Mon; 2004 Nov; 10(11):414-5, 432. PubMed ID: 15744891
    [No Abstract]   [Full Text] [Related]  

  • 11. IL-2 low dose and treatment interruption: interview with Kendall A. Smith. Interview by John S. James.
    Smith KA
    AIDS Treat News; 1999 Oct; (No 329):1-6. PubMed ID: 11366819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scientific and ethical considerations in trial design for investigational agents for the treatment of human immunodeficiency virus infection.
    Feinberg J; Japour AJ
    Clin Infect Dis; 2003 Jan; 36(2):201-6. PubMed ID: 12522753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activism today: the Coalition for Salvage Therapy. Interview with Linda Grinberg. Interview by John S. James.
    Grinberg L
    AIDS Treat News; 1999 Nov; (No 330):2-4. PubMed ID: 11367171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPC-083. DuPont Pharmaceuticals.
    Lim ML
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1209-12. PubMed ID: 11717806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA clarifies rules, allows combining antiretrovirals in clinical trials. Food and Drug Administration.
    AIDS Treat News; 1999 Nov; (No 331):5-6. PubMed ID: 11367127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOTC also goes down.
    Posit Aware; 2000; 11(1):23. PubMed ID: 11366340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymitaq (Zarix).
    Niculescu-Duvaz I
    Curr Opin Investig Drugs; 2001 May; 2(5):693-705. PubMed ID: 11569949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment interruption; advanced HIV; new ideas: Dr. Cal Cohen interview on retrovirus conference (part 2 or 2). Interview by John S. James.
    Cohen C
    AIDS Treat News; 2003 Apr; (390):2-5. PubMed ID: 12739473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
    AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.